Co-medication with cannabidiol temporarily slowed progression of amyotrophic lateral sclerosis

Stephen Goldner
Jul 24, 2017 · 1 min read

Co-medication with cannabidiol was able to improve significant symptoms in a patient with amyotrophic lateral sclerosis according to an article by an Austrian scientist. He wrote that “about eighteen months ago, the patient, a general practitioner at the beginning of his sixties, observed a painless weakness and impaired function of his right hand.” Despite treatment with riluzole, symptoms progressed relatively fast. Therefore, the patient decided to take cannabidiol (CBD, 2 × 200 mg/day) as co-medication and increased to a daily dose of 2 × 300 mg.

The author wrote, “Within 6 weeks, the impaired function of the right hand and foot reversed almost completely and dysphagia [impaired food intake] partially. Improvement was maintained for about 10 weeks, when again a slow progression” of symptoms was observed.

Nahler J. Co-medication with cannabidiol may slow down the progression of motor neuron disease: a case report. Gen Pract (Los Angel) 2017;5:4.

Stephen Goldner

Written by

CEO of C³ Cannabis Consulting, drug inventor, FDA lawyer, President of Regulatory Affairs Associates

Welcome to a place where words matter. On Medium, smart voices and original ideas take center stage - with no ads in sight. Watch
Follow all the topics you care about, and we’ll deliver the best stories for you to your homepage and inbox. Explore
Get unlimited access to the best stories on Medium — and support writers while you’re at it. Just $5/month. Upgrade